These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 7721493)

  • 41. Enalapril reduces QTc dispersion in mild congestive heart failure secondary to coronary artery disease.
    Barr CS; Naas AA; Fenwick M; Struthers AD
    Am J Cardiol; 1997 Feb; 79(3):328-33. PubMed ID: 9036753
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Enalapril. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in hypertension and congestive heart failure.
    Todd PA; Heel RC
    Drugs; 1986 Mar; 31(3):198-248. PubMed ID: 3011386
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Analysis of heart rate variability five minutes before the onset of paroxysmal atrial fibrillation.
    Fioranelli M; Piccoli M; Mileto GM; Sgreccia F; Azzolini P; Risa MP; Francardelli RL; Venturini E; Puglisi A
    Pacing Clin Electrophysiol; 1999 May; 22(5):743-9. PubMed ID: 10353133
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Acute and long-term effects of the angiotensin-converting enzyme inhibitor, enalapril, on adrenergic activity and sensitivity during exercise in patients with left ventricular systolic dysfunction.
    Patten RD; Kronenberg MW; Benedict CR; Udelson JE; Kinan D; Stewart D; Yusuf S; Smith JJ; Kilcoyne L; Dolan N; Edens TR; Metherall J; Konstam MA
    Am Heart J; 1997 Jul; 134(1):37-43. PubMed ID: 9266781
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Sustained augmentation of parasympathetic tone with angiotensin-converting enzyme inhibition in patients with congestive heart failure.
    Binkley PF; Haas GJ; Starling RC; Nunziata E; Hatton PA; Leier CV; Cody RJ
    J Am Coll Cardiol; 1993 Mar; 21(3):655-61. PubMed ID: 8436747
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [The use of lisinopril for congestive heart failure].
    Amodeo C
    Arq Bras Cardiol; 1990 Aug; 55 Suppl A():A14-7. PubMed ID: 1965521
    [No Abstract]   [Full Text] [Related]  

  • 47. QT interval dispersion and cardiac sympathovagal balance shift in rats with acute ethanol withdrawal.
    Shirafuji S; Liu J; Okamura N; Hamada K; Fujimiya T
    Alcohol Clin Exp Res; 2010 Feb; 34(2):223-30. PubMed ID: 19951299
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Clinical pharmacokinetics of the angiotensin converting enzyme inhibitors. A review.
    Kubo SH; Cody RJ
    Clin Pharmacokinet; 1985; 10(5):377-91. PubMed ID: 2994938
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Differences in first dose response to angiotensin converting enzyme inhibition in congestive heart failure: a placebo controlled study.
    MacFadyen RJ; Lees KR; Reid JL
    Br Heart J; 1991 Sep; 66(3):206-11. PubMed ID: 1657084
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Reduction of sympathetic hyperactivity by enalapril in patients with chronic renal failure.
    Ligtenberg G; Blankestijn PJ; Oey PL; Klein IH; Dijkhorst-Oei LT; Boomsma F; Wieneke GH; van Huffelen AC; Koomans HA
    N Engl J Med; 1999 Apr; 340(17):1321-8. PubMed ID: 10219067
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Curcuminoids: Spicing up sympathovagal tone.
    Katz PS; Trask AJ; Lucchesi PA
    Nutrition; 2009; 25(7-8):879-80. PubMed ID: 19539177
    [No Abstract]   [Full Text] [Related]  

  • 52. [Evaluation of the effect of enalapril, a converting enzyme inhibitor, on lymphocytic beta-adrenergic receptors of patients with chronic cardiac insufficiency].
    Lavandero S; Martínez S; Guarda E; Corbalán R; Cartagena G; Jalil JE; Foncea R; Ebensperger R; Godoy I; Casanegra P
    Rev Esp Cardiol; 1992 Oct; 45(8):525-30. PubMed ID: 1335161
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Different results in cardiopulmonary exercise tests after long-term treatment with felodipine and enalapril in patients with congestive heart failure due to ischaemic heart disease.
    Dunselman PH; van der Mark TW; Kuntze CE; van Bruggen A; Hamer JP; Scaf AH; Wesseling H; Lie KI
    Eur Heart J; 1990 Mar; 11(3):200-6. PubMed ID: 2318222
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Effects of converting enzyme inhibitors: ramipril and enalapril on peptide action and sympathetic neurotransmission in the isolated heart.
    Xiang JZ; Linz W; Becker H; Ganten D; Lang RE; Schölkens B; Unger T
    Eur J Pharmacol; 1985 Jul; 113(2):215-23. PubMed ID: 2995065
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Long term use of enalapril in the treatment of patients with congestive heart failure.
    Joy M; Hubner PJ; Thomas RD; Cummin P; Dews I; Williams H; Shahrabani R
    Int J Cardiol; 1987 Aug; 16(2):137-44. PubMed ID: 3040605
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [State of the sympathetic-adrenal system in congestive cardiac insufficiency].
    Korochkin IM; Oganov RG
    Kardiologiia; 1973 Mar; 13(3):140-51. PubMed ID: 4149940
    [No Abstract]   [Full Text] [Related]  

  • 57. Low-dose enalapril reduces angiotensin II and attenuates diabetic-induced cardiac and autonomic dysfunctions.
    Malfitano C; De Angelis K; Fernandes T; Wichi RB; Rosa K; Pazzine M; Mostarda C; Ronchi FA; Oliveira EM; Casarini DE; Irigoyen MC
    J Cardiovasc Pharmacol; 2012 Jan; 59(1):58-65. PubMed ID: 21921804
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Neurohumoral effects of digoxin: a target for further investigation.
    Gheorghiade M
    Cardiologia; 1996 Oct; 41(10):967-72. PubMed ID: 8940784
    [No Abstract]   [Full Text] [Related]  

  • 59. Concurrent alpha 1 adrenergic blockade and angiotensin converting enzyme inhibition in the treatment of congestive heart failure.
    Ajayi AA; Sofowora GG; Balogun MO
    Int J Cardiol; 1996 Dec; 57(2):173-6. PubMed ID: 9013270
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Comparison of candesartan, enalapril, and their combination in congestive heart failure: randomized evaluation of strategies for left ventricular dysfunction (RESOLVD) pilot study. The RESOLVD Pilot Study Investigators.
    McKelvie RS; Yusuf S; Pericak D; Avezum A; Burns RJ; Probstfield J; Tsuyuki RT; White M; Rouleau J; Latini R; Maggioni A; Young J; Pogue J
    Circulation; 1999 Sep; 100(10):1056-64. PubMed ID: 10477530
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.